Ambulatory hypercholesterolemia management in patients with atherosclerosis. Gender and race differences in processes

Stephen D Persell1, Saverio M Maviglia, David W Bates

  • 1Division of General Internal Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611-2927, USA. spersell@nmff.org

Insights

Cholesterol management was less intensive for women than men, contributing to poorer cholesterol control in women. Management was similar for Black and White patients, with no disparity in control observed between these groups.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Atherosclerosis requires diligent cholesterol management to prevent cardiovascular events.
  • Understanding disparities in cholesterol management is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate gender and racial differences in outpatient cholesterol management for patients with atherosclerosis.
  • To identify factors influencing cholesterol control in this population.

Main Methods:

  • Retrospective cohort study of 243 patients with established atherosclerotic disease and elevated LDL-C (>130 mg/dl).
  • Analysis of 1,082 office visits to assess cholesterol management processes (medication intensification, LDL-C monitoring).
  • Evaluation of factors associated with achieving LDL-C <130 mg/dl after one year.

Main Results:

  • Cholesterol management occurred less frequently for women (31.2%) compared to men (38.5%) (P=.01).
  • Management intensity was similar between Black (37.3%) and White (31.7%) patients (P=.09).
  • Women (41%) and Black patients (39%) achieved LDL-C <130 mg/dl less often than men (61%) and White patients (58%), respectively.

Conclusions:

  • Cholesterol management intensity was lower for women than men, partially explaining gender-based disparities in cholesterol control.
  • No significant disparities in cholesterol management or control were found between Black and White patients.
  • Outpatient cholesterol management for atherosclerosis may be influenced by patient gender, necessitating targeted interventions.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...